Post-event Feedback Survey
Thank you for attending the MPE 10th Anniversary and Masterclass 2021! Your feedback will help us to improve your experience at future events.
1.
I am a
MPE Member
Patient
Advocate
Carer
Health Care Professional
Pharmaceutical industry representative
Other
2.
How relevant were the event sessions to you on Friday, July 2?
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Early detection and diagnosis of MGUS and SMM
María-Victoria Mateos
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
New developments and controversies in myeloma
Mohamad Mohty
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
COVID-19 and its effect on myeloma and AL amyloidosis patients
Mohamad Mohty
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
MPE members' resiliency during COVID-19
Emilia Demczur and Varda Shoham
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Comment
3.
Was the content of the sessions on July 2 easy to understand?
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Early detection and diagnosis of MGUS and SMM
María-Victoria Mateos
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
New developments and controversies in myeloma
Mohamad Mohty
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
COVID-19 and its effect on myeloma and AL amyloidosis patients
Mohamad Mohty
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
MPE members' resiliency during COVID-19
Emilia Demczur and Varda Shoham
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Comment
4.
How relevant were the event sessions to you on Saturday, July 3?
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Developments in AL amyloidosis
Monique Minnema
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Myeloma related diseases
Paolo Milani
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Immunotherapy in the treatment of myeloma and AL amyloidosis
María-Victoria Mateos
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
A clinical perspective on access in central and eastern Europe
Roman Hájek
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Palliative care and quality of life
Christina Gerlach
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Fundraising for patient groups and collaboration with industry
Jan Geissler
Extremely relevant
Very relevant
Somewhat relevant
Not so relevant
Not at all relevant
N/A
Comment
5.
Was the content of the sessions on July 3 easy to understand?
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Developments in AL amyloidosis
Monique Minnema
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Myeloma related diseases
Paolo Milani
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Immunotherapy in the treatment of myeloma and AL amyloidosis
María-Victoria Mateos
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
A clinical perspective on access in central and eastern Europe
Roman Hájek
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Palliative care and quality of life
Christina Gerlach
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Fundraising for patient groups and collaboration with industry
Jan Geissler
Extremely easy to understand
Very easy to understand
Somewhat easy to understand
Not so easy to understand
Not at all easy to understand
N/A
Comment
6.
Tell us your thoughts on the MRD panel on Saturday, July 3? Check all that apply.
The Patient Perspective presentation was relevant
The Clinical Perspective presentation was relevant
The Regulator Perspective presentation was relevant
The information was presented in a way that was clear and easy to understand
The moderator was effective in facilitating a thoughtful discussion
The discussion was interesting and relevant to my work
Comment
7.
Overall, what did you think about the moderation of the sessions?
Excellent
Very good
Good
Fair
Poor
Comment
8.
Tell us your thoughts about the event organization. Check all that apply.
The date of the Masterclass was provided with appropriate notice
The agenda was provided with appropriate notice
The logistics and details were communicated clearly
The virtual platform was easy to use
MPE staff were helpful when I had questions or a problem
The event was organized well and ran smoothly
Comment
9.
What topics would you suggest for the MPE Masterclass 2022?
10.
Was there anything specific you liked about the Masterclass or found particularly valuable?
11.
Was there anything you disliked about the Masterclass and do you have suggestions for future improvements?
